Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.964 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.95 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9209 |
High Similarity |
NPD1549 |
Phase 2 |
0.9137 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9137 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.913 |
High Similarity |
NPD1510 |
Phase 2 |
0.9118 |
High Similarity |
NPD1240 |
Approved |
0.9065 |
High Similarity |
NPD2796 |
Approved |
0.8986 |
High Similarity |
NPD1607 |
Approved |
0.898 |
High Similarity |
NPD7411 |
Suspended |
0.8912 |
High Similarity |
NPD4380 |
Phase 2 |
0.8859 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8808 |
High Similarity |
NPD7075 |
Discontinued |
0.88 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8792 |
High Similarity |
NPD6801 |
Discontinued |
0.8759 |
High Similarity |
NPD1511 |
Approved |
0.8733 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8733 |
High Similarity |
NPD7819 |
Suspended |
0.8681 |
High Similarity |
NPD3750 |
Approved |
0.8639 |
High Similarity |
NPD1512 |
Approved |
0.863 |
High Similarity |
NPD6799 |
Approved |
0.8611 |
High Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8609 |
High Similarity |
NPD2801 |
Approved |
0.8562 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8543 |
High Similarity |
NPD1934 |
Approved |
0.8497 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8483 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8483 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8471 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8442 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8411 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8377 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8333 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8333 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8322 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8313 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8298 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8298 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8288 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.828 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8276 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8276 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8219 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8212 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8212 |
Intermediate Similarity |
NPD920 |
Approved |
0.8201 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8194 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8188 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.811 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8098 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8086 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.8082 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8079 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8079 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8054 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8042 |
Intermediate Similarity |
NPD3268 |
Approved |
0.8027 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8027 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8014 |
Intermediate Similarity |
NPD2798 |
Approved |
0.8 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7987 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7986 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7975 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7963 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7961 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7961 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7961 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7959 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7959 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7943 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7939 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7933 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD943 |
Approved |
0.7927 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7927 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7917 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7911 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7902 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7883 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7879 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7852 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7848 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7831 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7815 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7812 |
Intermediate Similarity |
NPD919 |
Approved |
0.7784 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7778 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7778 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7758 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7755 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7755 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7724 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7716 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7692 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7692 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7687 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7679 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.766 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7657 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7644 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7632 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7625 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7622 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7606 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7605 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7595 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7562 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7547 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7516 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7482 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7448 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7448 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7438 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7438 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7434 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7434 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7434 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7434 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7432 |
Intermediate Similarity |
NPD411 |
Approved |
0.7431 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7421 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7415 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7414 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7413 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7407 |
Intermediate Similarity |
NPD2296 |
Approved |
0.74 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7391 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7381 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.7377 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7355 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7349 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7349 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7347 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7279 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD17 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7241 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.717 |
Intermediate Similarity |
NPD4662 |
Approved |
0.717 |
Intermediate Similarity |
NPD4661 |
Approved |
0.716 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7126 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7115 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7105 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7102 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7097
|
Intermediate Similarity |
NPD4477 |
Approved |